Chapter 24: Hematologic & Immunologic Dysfunction in Children

The text explores the pathophysiology and management of anemia, defined as a reduction in red blood cell (RBC) mass or hemoglobin concentration, which diminishes the oxygen-carrying capacity of the blood and can lead to growth retardation and cardiac strain. A significant portion of the chapter is dedicated to Iron-Deficiency Anemia, the most prevalent nutritional disorder in children, often caused by excessive cow's milk intake ("milk babies") or inadequate iron stores in preterm infants, necessitating dietary counseling and oral iron supplementation with Vitamin C to enhance absorption. The discussion advances to hemoglobinopathies, specifically Sickle Cell Anemia (SCA), an autosomal recessive disease where normal hemoglobin is replaced by HbS, leading to RBC sickling, vascular obstruction, inflammation, and tissue ischemia. Key management strategies for SCA include hydration, pain management for vasoocclusive crises, penicillin prophylaxis to prevent pneumococcal sepsis, and monitoring for life-threatening complications like acute chest syndrome and stroke. The chapter also details Beta Thalassemia (Cooley Anemia), characterized by defective hemoglobin synthesis and chronic hypoxia, where therapeutic management focuses on frequent transfusions and chelation therapy to manage iron overload (hemosiderosis). Aplastic Anemia is described as a condition of pancytopenia (simultaneous depression of all blood elements) resulting in bone marrow failure, treated with immunosuppressive therapy or hematopoietic stem cell transplantation (HSCT). The summary continues with defects in hemostasis, highlighting Hemophilia A and B as X-linked recessive disorders involving Factor VIII or IX deficiencies, where preventing hemarthrosis (joint bleeding) via factor replacement and injury prevention is paramount. Immune Thrombocytopenia (ITP), an acquired hemorrhagic disorder involving autoimmune platelet destruction often following a viral illness, is discussed alongside therapeutic interventions like anti-D antibody administration and splenectomy for chronic cases. Disseminated Intravascular Coagulation (DIC) is explained as a secondary disorder characterized by simultaneous clotting and bleeding due to diffuse fibrin deposition. Finally, the chapter covers immunologic deficiency disorders, detailing the management of Human Immunodeficiency Virus (HIV) in children, emphasizing the decline in vertical transmission due to antiretroviral therapy (ART) and the need for prophylaxis against opportunistic infections like Pneumocystis carinii pneumonia. Severe Combined Immunodeficiency Disease (SCID) and Wiskott-Aldrich Syndrome are presented as profound immune defects requiring aggressive intervention such as HSCT to prevent fatal infections. The chapter concludes with the nursing responsibilities regarding blood transfusion therapy, including the identification and management of hemolytic, febrile, and allergic reactions.